Manifesto
The event is late. The claim changes first.
NextConsensus is a pre-consensus intelligence company. We measure when contested biotech safety and regulatory claims begin hardening into decision-grade risk.
The Consensus Gap
In biotech, the formal event—a label change, a trial hold, a regulatory disclosure—is often the end of a process, not the beginning.
Before the event, there is a period of contestation. Claims are made, challenged, reframed, and evidenced. This is the period of pre-consensus.
Most systems watch the events. We measure the phase before the events.
Claim-State Measurement
We track claim-state. A claim is not just a sentence; it is a unit of institutional meaning that moves through distinct phases:
- Contested: The claim is being actively debated or dismissed.
- Hardening: The claim is becoming harder to deny, its evidence base is anchoring, and its wording is stabilizing.
- Hardened: The claim has become institutionally durable, even if not yet official.
- Official: The claim is adopted by a formal institution (FDA, Guideline, Label).
The Mission
Our mission is to provide the healthcare value chain with the tools to identify institutional risk before it becomes official. We believe that better measurement of emerging consensus leads to faster, safer, and more accurate healthcare decisions.
Action